Could Ketamine Become The Next Great Depression Drug?
Long used as an anesthetic and sedative in hospital rooms and framed in recent years as a harmful recreational club drug, the perception of ketamine is getting reinvented yet again. This time, through years of research, ketamine is showing promise as a tool for future depression treatments. And since 2012, studies from Yale University, Houston’s Baylor College of Medicine and New York’s Icahn School of Medicine at Mount Sinai found that ketamine is overwhelmingly successful for treatment-resistant patients.
- Icahn School of Medicine at Mount Sinai

Mount Sinai Surgeons Perform First Heart-Liver-Kidney Transplants in New York State
May 20, 2025 View All Press Releases
Mount Sinai Study Advances Understanding of Personalized Vaccines for Bladder Cancer
May 12, 2025 View All Press Releases